A Study on the Combination Therapy of Eravacycline for Treating Carbapenem-Resistant Acinetobacter Baumannii Pneumonia
Clinical trial NCT06670872 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06670872
- Sponsor
- Peking University Third Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-01
- Primary completion
- 2025-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.